Of the acute respiratory viral infections in the farms of the Udmurt Republic, parainfluenza-3, respiratory syncytial infection, infectious rhinotracheitis, viral diarrhea are the most common. For the prevention of these cattle diseases, the inactivated combined vaccine Kombovak and Kombovak R. is used. Despite the widespread use of this vaccine, there is an ambiguous situation in the farms of UR and the percentage of ARVI incidence is extremely variable. Along with general economic factors, this can be explained using different schemes for the use of the vaccine. The work was carried out in the conditions of an industrial livestock complex located in the Uvinsky district of the Udmurt Republic. During the period of the work, 1,383 heads of cattle vaccinated with the Kombovak-R vaccine were monitored. Laboratory tests were carried out in the BI UR "Udmurt Veterinary Diagnostic Center" in the city of Izhevsk and LLC "Independent Veterinary Laboratory "Chance-Bio" in the city of Moscow. Determination of immunity intensity and retrospective serological diagnosis of ARVI was carried out by examining paired blood serum samples. Blood serum samples were taken from clinically healthy cows at the 6th month of pregnancy, i.e. at the end of the inter-vaccination period, as well as from unvaccinated calves with a live weight of 50-55 kg at the age of 17-18 days and after 21 days, respectively. When studying the preservation of post-vaccination immunity in cows, it was found that only two out of five studied animals have a protective level of antibodies to acute respiratory viral infections by the end of the inter-vaccination period. Serological screening of calves showed that antibodies to the pathogens of IRT, VD, RSI and PI-3 were determined in all samples. nevertheless, the titers of antibodies to ARVI pathogens differed significantly.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.